The latest ovarian cancer news and blogs from Target Ovarian Cancer, including fundraising, campaigns, research and support news, and blogs from people affected by ovarian cancer. Scroll down for our events listings, including support and fundraising events.

Information is correct at the time of publication, please note information in historical news stories around drug availability or statistics may not still be relevant.

News
Researching the immune system to tackle ovarian cancer
Wednesday 3 June 2020
This week our immunotherapy project led by Dr Martin Miller at the University of Cambridge revealed an important new piece of the puzzle of developing more effective treatments for the most common form of ovarian cancer. The paper, published in high-profile journal Nature Genetics, has uncovered...
News
Searching new treatments for low grade serous ovarian cancer
Wednesday 29 January 2020
Target Ovarian Cancer is announcing a brand new award for research into a less common type of this disease. Our new project will find new ways to treat low grade serous ovarian cancer. Because this type of ovarian cancer affects a smaller group of women than other types (around 700 women each year...
News
Monday 9 December 2019
The Scottish Medicines Consortium (SMC) has joined the National Institute for Health and Care Excellence (NICE) by approving a breakthrough ovarian cancer drug from the first round of treatment, meaning it is now available across the UK. Olaparib (Lynparza®) is one of a new generation of drugs...
News
Donate
Friday 27 September 2019
News from the European Society of Medical Oncology (ESMO) conference means more women could be able to access innovative treatments earlier. Three announcements on the benefits of a new generation of ovarian cancer drugs, PARP inhibitors, were made over the weekend at the research conference in...

Pages